Recently, ortho-vanillin (O-Vanillin) was shown to block TLR2-mediated signaling and lower the levels of IL-6, inducible nitric oxide synthase (iNOS), MT1-MMP, and MMP9, to attenuate GBM growth and invasion (40). The gene discussed is MMP9; the disease is glioblastoma.